CTNNB1 shRNA

CTNNB1 shRNA refers to short hairpin RNA molecules specifically designed to target the CTNNB1 gene, which encodes for beta-catenin. This therapeutic approach utilizes the RNA interference (RNAi) pathway to silence gene expression. Upon delivery into cells, shRNA is processed into small interfering RNA (siRNA) by the cellular machinery. These siRNAs then guide the RNA-induced silencing complex (RISC) to complementary messenger RNA (mRNA) molecules of the CTNNB1 gene, leading to their degradation. This process effectively inhibits the production of the beta-catenin protein. Dysregulation of beta-catenin, particularly its aberrant activation, is implicated in various pathological conditions, most notably in the development and progression of numerous cancers. Therefore, CTNNB1 shRNA is being investigated as a potential therapeutic strategy to reduce beta-catenin levels and thereby inhibit tumor growth, metastasis, and overcome drug resistance in cancer. It is also being explored for other diseases where CTNNB1 dysregulation plays a role, such as neurodegenerative disorders. Delivery methods often involve viral vectors (e.g., lentiviruses) for stable expression or non-viral carriers like nanoparticles for systemic or local administration.

Other names

CTNNB1 shRNACTNNB-1 shRNACTNNB 1 shRNAbeta-catenin short hairpin RNAβ-catenin shRNA